David Kimball Urion, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurology | 6 | 2020 | 785 | 0.860 |
Why?
|
| Pediatrics | 8 | 2020 | 3621 | 0.600 |
Why?
|
| Kleine-Levin Syndrome | 1 | 2014 | 4 | 0.470 |
Why?
|
| Lethargy | 1 | 2014 | 43 | 0.450 |
Why?
|
| Problem-Based Learning | 1 | 2017 | 360 | 0.440 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2014 | 279 | 0.350 |
Why?
|
| Behavioral Sciences | 1 | 2009 | 28 | 0.330 |
Why?
|
| Curriculum | 3 | 2020 | 3786 | 0.330 |
Why?
|
| Cerebellum | 1 | 2015 | 1521 | 0.290 |
Why?
|
| Internship and Residency | 5 | 2020 | 5947 | 0.290 |
Why?
|
| Ethmoid Bone | 1 | 2005 | 35 | 0.250 |
Why?
|
| Basilar Membrane | 1 | 2005 | 50 | 0.250 |
Why?
|
| Education, Medical, Continuing | 1 | 2009 | 829 | 0.230 |
Why?
|
| Sphenoid Bone | 1 | 2005 | 176 | 0.220 |
Why?
|
| Amnesia, Transient Global | 1 | 2003 | 19 | 0.220 |
Why?
|
| Meningitis, Bacterial | 1 | 2005 | 222 | 0.210 |
Why?
|
| Congenital Abnormalities | 3 | 2017 | 703 | 0.190 |
Why?
|
| Nervous System Diseases | 4 | 2017 | 1660 | 0.180 |
Why?
|
| Pneumococcal Infections | 1 | 2005 | 529 | 0.170 |
Why?
|
| Cognition Disorders | 2 | 2014 | 3968 | 0.170 |
Why?
|
| Autistic Disorder | 1 | 2009 | 1239 | 0.170 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 134 | 0.150 |
Why?
|
| Neurologic Examination | 5 | 2017 | 913 | 0.150 |
Why?
|
| Neuromuscular Diseases | 1 | 2020 | 260 | 0.140 |
Why?
|
| Stereotypic Movement Disorder | 1 | 2017 | 31 | 0.140 |
Why?
|
| Accreditation | 1 | 2020 | 477 | 0.140 |
Why?
|
| Mutagenesis, Insertional | 1 | 2019 | 661 | 0.140 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2019 | 462 | 0.140 |
Why?
|
| Interdisciplinary Communication | 2 | 2014 | 935 | 0.130 |
Why?
|
| Myokymia | 1 | 2015 | 11 | 0.130 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2015 | 29 | 0.130 |
Why?
|
| Rett Syndrome | 1 | 2017 | 164 | 0.120 |
Why?
|
| Cataplexy | 1 | 2015 | 62 | 0.120 |
Why?
|
| Oligonucleotides | 1 | 2018 | 561 | 0.120 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2018 | 260 | 0.120 |
Why?
|
| Respiratory Aspiration | 1 | 2015 | 89 | 0.120 |
Why?
|
| Explosive Agents | 1 | 2014 | 26 | 0.120 |
Why?
|
| Verbal Behavior | 1 | 2015 | 328 | 0.110 |
Why?
|
| Rare Diseases | 1 | 2019 | 630 | 0.110 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 1029 | 0.110 |
Why?
|
| DNA Copy Number Variations | 2 | 2014 | 2047 | 0.110 |
Why?
|
| Feedback | 1 | 2017 | 797 | 0.110 |
Why?
|
| Child | 25 | 2021 | 80771 | 0.110 |
Why?
|
| Ataxia | 1 | 2015 | 307 | 0.110 |
Why?
|
| Clinical Competence | 2 | 2020 | 4859 | 0.100 |
Why?
|
| Firesetting Behavior | 1 | 1992 | 5 | 0.100 |
Why?
|
| Ethics, Medical | 1 | 2018 | 785 | 0.100 |
Why?
|
| Larynx | 1 | 2017 | 492 | 0.100 |
Why?
|
| Hand | 1 | 2017 | 910 | 0.100 |
Why?
|
| Chromosome Disorders | 1 | 2014 | 498 | 0.090 |
Why?
|
| Program Development | 1 | 2017 | 1298 | 0.090 |
Why?
|
| Chickenpox | 1 | 1992 | 95 | 0.090 |
Why?
|
| Somatoform Disorders | 1 | 2014 | 425 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2015 | 36582 | 0.090 |
Why?
|
| Cerebellar Ataxia | 1 | 1992 | 151 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2011 | 313 | 0.080 |
Why?
|
| Brain Injuries | 1 | 2021 | 2053 | 0.080 |
Why?
|
| Running | 1 | 2014 | 489 | 0.080 |
Why?
|
| Acetamides | 1 | 2011 | 259 | 0.080 |
Why?
|
| Epilepsy | 3 | 2014 | 3317 | 0.080 |
Why?
|
| Program Evaluation | 1 | 2017 | 2505 | 0.080 |
Why?
|
| Neuropsychology | 1 | 2009 | 110 | 0.080 |
Why?
|
| Heart Defects, Congenital | 2 | 2015 | 4713 | 0.080 |
Why?
|
| 1,4-alpha-Glucan Branching Enzyme | 1 | 2008 | 4 | 0.080 |
Why?
|
| Glycogen Storage Disease Type IV | 1 | 2008 | 7 | 0.080 |
Why?
|
| Disasters | 1 | 2014 | 521 | 0.080 |
Why?
|
| Encephalitis | 1 | 1992 | 441 | 0.070 |
Why?
|
| Photic Stimulation | 2 | 1992 | 1989 | 0.070 |
Why?
|
| Language Disorders | 1 | 1988 | 140 | 0.070 |
Why?
|
| Child Behavior Disorders | 1 | 1992 | 812 | 0.070 |
Why?
|
| Epilepsies, Partial | 1 | 2011 | 431 | 0.070 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2007 | 107 | 0.070 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 1512 | 0.070 |
Why?
|
| Neuropsychological Tests | 3 | 2019 | 7121 | 0.070 |
Why?
|
| Developmental Disabilities | 3 | 2015 | 1518 | 0.070 |
Why?
|
| Motor Activity | 2 | 2015 | 2713 | 0.070 |
Why?
|
| Humans | 38 | 2021 | 767040 | 0.060 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2010 | 597 | 0.060 |
Why?
|
| Male | 29 | 2021 | 364203 | 0.060 |
Why?
|
| Emergency Medicine | 1 | 2014 | 1220 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 12986 | 0.060 |
Why?
|
| Pilot Projects | 1 | 2017 | 8732 | 0.060 |
Why?
|
| Adolescent | 11 | 2018 | 89046 | 0.060 |
Why?
|
| Cyanosis | 1 | 2003 | 82 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 4054 | 0.050 |
Why?
|
| Polycythemia | 1 | 2003 | 124 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3112 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2014 | 1936 | 0.050 |
Why?
|
| Child, Preschool | 10 | 2021 | 42606 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3234 | 0.050 |
Why?
|
| Astrocytoma | 1 | 2007 | 773 | 0.050 |
Why?
|
| Steroids | 1 | 2007 | 937 | 0.050 |
Why?
|
| Teaching | 1 | 2009 | 1172 | 0.050 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2007 | 551 | 0.050 |
Why?
|
| Functional Laterality | 1 | 1988 | 2245 | 0.050 |
Why?
|
| Recurrence | 1 | 2014 | 8504 | 0.050 |
Why?
|
| Models, Neurological | 1 | 2009 | 1747 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2011 | 1921 | 0.050 |
Why?
|
| Vitreous Body | 1 | 1983 | 401 | 0.050 |
Why?
|
| Fellowships and Scholarships | 1 | 2009 | 1135 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2008 | 1424 | 0.040 |
Why?
|
| Retrospective Studies | 8 | 2021 | 81659 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2017 | 4746 | 0.040 |
Why?
|
| Electroencephalography | 5 | 2019 | 6282 | 0.040 |
Why?
|
| Glasgow Coma Scale | 1 | 2021 | 574 | 0.040 |
Why?
|
| Female | 21 | 2021 | 396660 | 0.040 |
Why?
|
| Potassium | 1 | 1983 | 1314 | 0.040 |
Why?
|
| Infant | 8 | 2018 | 36485 | 0.040 |
Why?
|
| Boston | 3 | 2017 | 9360 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2013 | 3854 | 0.040 |
Why?
|
| Acetates | 1 | 1979 | 314 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2009 | 2516 | 0.040 |
Why?
|
| Drugs, Investigational | 1 | 2019 | 211 | 0.040 |
Why?
|
| Mutation | 2 | 2015 | 30211 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2010 | 3591 | 0.030 |
Why?
|
| Seizures | 2 | 2019 | 2996 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 1988 | 2255 | 0.030 |
Why?
|
| Adult | 7 | 2020 | 223317 | 0.030 |
Why?
|
| Sequence Deletion | 2 | 2011 | 1494 | 0.030 |
Why?
|
| Growth Substances | 1 | 2017 | 759 | 0.030 |
Why?
|
| Fundoplication | 1 | 2015 | 145 | 0.030 |
Why?
|
| Biopsy | 2 | 2019 | 6777 | 0.030 |
Why?
|
| Gastrostomy | 1 | 2015 | 325 | 0.030 |
Why?
|
| Fatal Outcome | 2 | 2008 | 1836 | 0.030 |
Why?
|
| Hypoglycemia | 1 | 1979 | 896 | 0.020 |
Why?
|
| Hepatic Encephalopathy | 1 | 1993 | 143 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2015 | 735 | 0.020 |
Why?
|
| Video Recording | 1 | 2017 | 977 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2019 | 1068 | 0.020 |
Why?
|
| Tracheostomy | 1 | 2015 | 430 | 0.020 |
Why?
|
| Apraxias | 2 | 1992 | 58 | 0.020 |
Why?
|
| Neurofibromatosis 1 | 1 | 1996 | 561 | 0.020 |
Why?
|
| Chromosome Duplication | 1 | 2011 | 79 | 0.020 |
Why?
|
| Herpesvirus 3, Human | 1 | 1992 | 159 | 0.020 |
Why?
|
| Allelic Imbalance | 1 | 2011 | 77 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 1990 | 1559 | 0.020 |
Why?
|
| Aphasia | 1 | 1992 | 193 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 1992 | 616 | 0.020 |
Why?
|
| Young Adult | 5 | 2017 | 59980 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2007 | 7868 | 0.020 |
Why?
|
| Laryngoscopy | 1 | 2015 | 714 | 0.020 |
Why?
|
| Theta Rhythm | 1 | 1992 | 220 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2000 | 6023 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2015 | 913 | 0.020 |
Why?
|
| Deglutition Disorders | 1 | 2015 | 640 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 1939 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 1672 | 0.020 |
Why?
|
| Aging | 1 | 1988 | 8729 | 0.020 |
Why?
|
| Brain Edema | 1 | 1993 | 601 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 935 | 0.020 |
Why?
|
| Infant, Newborn | 4 | 2018 | 26396 | 0.020 |
Why?
|
| Gastroesophageal Reflux | 1 | 2015 | 834 | 0.020 |
Why?
|
| Karyotyping | 1 | 2010 | 1176 | 0.020 |
Why?
|
| Self Concept | 1 | 2013 | 1041 | 0.020 |
Why?
|
| Child Development | 1 | 2019 | 2329 | 0.020 |
Why?
|
| Pedigree | 1 | 2015 | 4539 | 0.020 |
Why?
|
| Oligoclonal Bands | 1 | 2007 | 17 | 0.020 |
Why?
|
| Hepatitis B | 1 | 1993 | 710 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 6507 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1992 | 1142 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2010 | 751 | 0.020 |
Why?
|
| Reflex, Stretch | 1 | 1986 | 22 | 0.020 |
Why?
|
| Pregnancy, High-Risk | 1 | 2007 | 121 | 0.020 |
Why?
|
| Health Personnel | 1 | 2020 | 3387 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2015 | 2592 | 0.020 |
Why?
|
| Consanguinity | 1 | 2008 | 460 | 0.020 |
Why?
|
| Referral and Consultation | 2 | 2017 | 3618 | 0.020 |
Why?
|
| Skin | 1 | 2019 | 4499 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 3797 | 0.020 |
Why?
|
| Ophthalmoplegia | 1 | 1987 | 168 | 0.020 |
Why?
|
| Methylprednisolone | 1 | 2007 | 386 | 0.020 |
Why?
|
| Central Nervous System Diseases | 1 | 1990 | 518 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 1996 | 2647 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2007 | 9108 | 0.020 |
Why?
|
| Saccades | 1 | 1987 | 230 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2011 | 1592 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 18063 | 0.020 |
Why?
|
| Interferon-beta | 1 | 2007 | 348 | 0.020 |
Why?
|
| Cerebellar Diseases | 1 | 2007 | 227 | 0.010 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2000 | 3724 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2019 | 12793 | 0.010 |
Why?
|
| Data Collection | 1 | 2013 | 3321 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2014 | 1951 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2021 | 41718 | 0.010 |
Why?
|
| Eye Movements | 1 | 1987 | 510 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2015 | 3207 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2008 | 1688 | 0.010 |
Why?
|
| Methotrexate | 1 | 1990 | 1718 | 0.010 |
Why?
|
| Ouabain | 1 | 1983 | 246 | 0.010 |
Why?
|
| Brain | 4 | 2015 | 27163 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 1743 | 0.010 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 39317 | 0.010 |
Why?
|
| Radiation Injuries | 1 | 1990 | 1196 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1983 | 2078 | 0.010 |
Why?
|
| Glutamates | 1 | 1983 | 384 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 3488 | 0.010 |
Why?
|
| Remission Induction | 1 | 2007 | 2408 | 0.010 |
Why?
|
| Exons | 1 | 2007 | 2391 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2015 | 9362 | 0.010 |
Why?
|
| Infant, Premature, Diseases | 1 | 1986 | 712 | 0.010 |
Why?
|
| Neuroprotective Agents | 1 | 2007 | 956 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1992 | 3212 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8736 | 0.010 |
Why?
|
| Parents | 1 | 2014 | 3594 | 0.010 |
Why?
|
| Alkalosis | 1 | 1979 | 55 | 0.010 |
Why?
|
| Ketone Bodies | 1 | 1979 | 76 | 0.010 |
Why?
|
| Pyruvates | 1 | 1979 | 84 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2007 | 1345 | 0.010 |
Why?
|
| Prenatal Diagnosis | 1 | 2007 | 1271 | 0.010 |
Why?
|
| Glycine | 1 | 1983 | 670 | 0.010 |
Why?
|
| Citrates | 1 | 1979 | 132 | 0.010 |
Why?
|
| Injections, Spinal | 2 | 1990 | 317 | 0.010 |
Why?
|
| Lactates | 1 | 1979 | 398 | 0.010 |
Why?
|
| Tuberous Sclerosis | 1 | 2007 | 1039 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 4114 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 9532 | 0.010 |
Why?
|
| Conduct Disorder | 1 | 2000 | 245 | 0.010 |
Why?
|
| United States | 2 | 2018 | 72971 | 0.010 |
Why?
|
| Acidosis | 1 | 1979 | 271 | 0.010 |
Why?
|
| Phenotype | 1 | 2015 | 16718 | 0.010 |
Why?
|
| Algorithms | 1 | 2017 | 14098 | 0.010 |
Why?
|
| Physicians | 1 | 2013 | 4593 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1992 | 5754 | 0.010 |
Why?
|
| Sodium | 1 | 1979 | 1594 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 10393 | 0.010 |
Why?
|
| Observer Variation | 1 | 2000 | 2616 | 0.010 |
Why?
|
| Syndrome | 2 | 1992 | 3271 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 1990 | 4422 | 0.010 |
Why?
|
| Superinfection | 1 | 1993 | 61 | 0.010 |
Why?
|
| Technetium Tc 99m Exametazime | 1 | 1992 | 61 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2008 | 4968 | 0.010 |
Why?
|
| Organotechnetium Compounds | 1 | 1992 | 134 | 0.010 |
Why?
|
| Encephalocele | 1 | 1993 | 135 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 1993 | 526 | 0.010 |
Why?
|
| Speech | 1 | 1996 | 555 | 0.010 |
Why?
|
| Oximes | 1 | 1992 | 305 | 0.010 |
Why?
|
| Psychometrics | 1 | 2000 | 3060 | 0.010 |
Why?
|
| Disease Progression | 1 | 2007 | 13646 | 0.010 |
Why?
|
| Social Behavior | 1 | 1996 | 1147 | 0.010 |
Why?
|
| Carrier State | 1 | 1993 | 529 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1990 | 11872 | 0.000 |
Why?
|
| Intelligence Tests | 1 | 1990 | 504 | 0.000 |
Why?
|
| Inflammation | 1 | 2007 | 10869 | 0.000 |
Why?
|
| Rats | 1 | 1983 | 23713 | 0.000 |
Why?
|
| Language | 1 | 1996 | 1550 | 0.000 |
Why?
|
| Risk Factors | 2 | 2011 | 74886 | 0.000 |
Why?
|
| Attention | 1 | 1996 | 2413 | 0.000 |
Why?
|
| Language Development Disorders | 1 | 1987 | 194 | 0.000 |
Why?
|
| Insulin | 1 | 1979 | 6602 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1979 | 6421 | 0.000 |
Why?
|
| Pregnancy | 1 | 2007 | 30238 | 0.000 |
Why?
|
| Temporal Lobe | 1 | 1992 | 1717 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 14672 | 0.000 |
Why?
|
| Mass Screening | 1 | 2000 | 5456 | 0.000 |
Why?
|
| Body Height | 1 | 1990 | 1565 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2000 | 15424 | 0.000 |
Why?
|
| Hepatitis C | 1 | 1993 | 1594 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 20169 | 0.000 |
Why?
|
| Middle Aged | 1 | 2015 | 223233 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2007 | 65295 | 0.000 |
Why?
|
| Animals | 2 | 1983 | 168965 | 0.000 |
Why?
|
| Body Weight | 1 | 1990 | 4627 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1990 | 8535 | 0.000 |
Why?
|
| Gestational Age | 1 | 1986 | 3618 | 0.000 |
Why?
|
| Socioeconomic Factors | 1 | 1990 | 7848 | 0.000 |
Why?
|
| Sex Factors | 1 | 1990 | 10622 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1992 | 8940 | 0.000 |
Why?
|
| Neurons | 1 | 1993 | 9517 | 0.000 |
Why?
|
| Mice | 1 | 1979 | 81912 | 0.000 |
Why?
|